148 related articles for article (PubMed ID: 29880282)
21. Multifunctional theranostic nanoplatform for cancer combined therapy based on gold nanorods.
Chen WH; Yang CX; Qiu WX; Luo GF; Jia HZ; Lei Q; Wang XY; Liu G; Zhuo RX; Zhang XZ
Adv Healthc Mater; 2015 Oct; 4(15):2247-59. PubMed ID: 26333115
[TBL] [Abstract][Full Text] [Related]
22. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
23. Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release.
Tang Q; Yu B; Gao L; Cong H; Song N; Lu C
Curr Med Chem; 2018; 25(16):1837-1866. PubMed ID: 29332566
[TBL] [Abstract][Full Text] [Related]
24. Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.
Kumar R; Shin WS; Sunwoo K; Kim WY; Koo S; Bhuniya S; Kim JS
Chem Soc Rev; 2015 Oct; 44(19):6670-83. PubMed ID: 26118960
[TBL] [Abstract][Full Text] [Related]
25. Vehicle-saving theranostic probes based on hydrophobic iron oxide nanoclusters using doxorubicin as a phase transfer agent for MRI and chemotherapy.
Cao Y; Min J; Zheng D; Li J; Xue Y; Yu F; Wu M
Chem Commun (Camb); 2019 Aug; 55(61):9015-9018. PubMed ID: 31290867
[TBL] [Abstract][Full Text] [Related]
26. Smart nanotheranostic hydrogels for on-demand cancer management.
Misra R; Acharya S
Drug Discov Today; 2021 Feb; 26(2):344-359. PubMed ID: 33212236
[TBL] [Abstract][Full Text] [Related]
27. A pH-Responsive Yolk-Like Nanoplatform for Tumor Targeted Dual-Mode Magnetic Resonance Imaging and Chemotherapy.
Sun X; Du R; Zhang L; Zhang G; Zheng X; Qian J; Tian X; Zhou J; He J; Wang Y; Wu Y; Zhong K; Cai D; Zou D; Wu Z
ACS Nano; 2017 Jul; 11(7):7049-7059. PubMed ID: 28665575
[TBL] [Abstract][Full Text] [Related]
28. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.
Chakraborty S; Dhakshinamurthy GS; Misra SK
J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475
[TBL] [Abstract][Full Text] [Related]
29. Metal nanoparticles: a theranostic nanotool against cancer.
Sharma H; Mishra PK; Talegaonkar S; Vaidya B
Drug Discov Today; 2015 Sep; 20(9):1143-51. PubMed ID: 26007605
[TBL] [Abstract][Full Text] [Related]
30. Newly Emerging Theranostic Agents for Simultaneous Cancertargeted Imaging and Therapy.
Luo S; Yang X; Shi C
Curr Med Chem; 2016; 23(5):483-97. PubMed ID: 26695513
[TBL] [Abstract][Full Text] [Related]
31. Light-induced liposomes for cancer therapeutics.
Chen W; Goldys EM; Deng W
Prog Lipid Res; 2020 Jul; 79():101052. PubMed ID: 32679153
[TBL] [Abstract][Full Text] [Related]
32. Intestinal toxicity evaluation of long-circulating and pH-sensitive liposomes loaded with cisplatin.
Araújo RS; Silveira ALM; de Sales E Souza ÉL; Freire RH; de Souza CM; Reis DC; Costa BRC; Sugimoto MA; Silveira JN; Dos Santos Martins F; Cassali GD; Leite JIA; Sousa LP; Ferreira AVM; Oliveira MC; Cardoso VN
Eur J Pharm Sci; 2017 Aug; 106():142-151. PubMed ID: 28546107
[TBL] [Abstract][Full Text] [Related]
33. Disintegrable NIR Light Triggered Gold Nanorods Supported Liposomal Nanohybrids for Cancer Theranostics.
Chauhan DS; Prasad R; Devrukhkar J; Selvaraj K; Srivastava R
Bioconjug Chem; 2018 May; 29(5):1510-1518. PubMed ID: 29281790
[TBL] [Abstract][Full Text] [Related]
34. Liposomal nanomedicine for breast cancer therapy.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
Nanomedicine (Lond); 2011 Aug; 6(6):1085-100. PubMed ID: 21955078
[TBL] [Abstract][Full Text] [Related]
35. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
Sharma R; Mody N; Agrawal U; Vyas SP
Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
[TBL] [Abstract][Full Text] [Related]
36. The influence of trapping agents on the antitumor efficacy of irinotecan liposomes: head-to-head comparison of ammonium sulfate, sulfobutylether-β-cyclodextrin and sucrose octasulfate.
Yang W; Yang Z; Fu J; Guo M; Sun B; Wei W; Liu D; Liu H
Biomater Sci; 2018 Dec; 7(1):419-428. PubMed ID: 30500018
[TBL] [Abstract][Full Text] [Related]
37. Theranostic barcoded nanoparticles for personalized cancer medicine.
Yaari Z; da Silva D; Zinger A; Goldman E; Kajal A; Tshuva R; Barak E; Dahan N; Hershkovitz D; Goldfeder M; Roitman JS; Schroeder A
Nat Commun; 2016 Nov; 7():13325. PubMed ID: 27830705
[TBL] [Abstract][Full Text] [Related]
38. Functional liposomes in the cancer-targeted drug delivery.
Tila D; Ghasemi S; Yazdani-Arazi SN; Ghanbarzadeh S
J Biomater Appl; 2015 Jul; 30(1):3-16. PubMed ID: 25823898
[TBL] [Abstract][Full Text] [Related]
39. A single-step multi-level supramolecular system for cancer sonotheranostics.
Lin H; Li S; Wang J; Chu C; Zhang Y; Pang X; Lv P; Wang X; Zhao Q; Chen J; Chen H; Liu W; Chen X; Liu G
Nanoscale Horiz; 2019 Jan; 4(1):190-195. PubMed ID: 32254155
[TBL] [Abstract][Full Text] [Related]
40. Nanopharmacology of liposomes developed for cancer therapy.
Muthu MS; Feng SS
Nanomedicine (Lond); 2010 Sep; 5(7):1017-9. PubMed ID: 20874016
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
